This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21–27 April 2024 and includes updates on respiratory virus epidemiology in the EU/EEA, West Nile virus, SARS-CoV-2 variant classification and Cholera.
From 23–26 April 2024, experts from the European Centre for Disease Prevention and Control (ECDC) and the African Centres for Disease Control and Prevention (Africa CDC) met in Stockholm, Sweden, to exchange expertise on surveillance, data management and epidemic intelligence.
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
A prolonged genomic cluster of 20 human Listeria monocytogenes ST1607 infections has been reported. The most recent case was reported in March 2024 in Denmark.
The annual European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) is taking place in Stockholm and online from 20-22 November 2024.